People living with HIV/AIDS in developing countries who are in urgent need of an improved version of the AIDS drug lopinavir/ritonavir continue to be denied access to it by its sole manufacturer, Abbott Laboratories, according to the international medical humanitarian organisation Médecins Sans Frontières (MSF).